Global Medical Response Solutions' IPO debuted 40% below its initial price range, reflecting investor caution due to high debt and challenges in the medical transportation sector. The company trades at a $7.1 billion enterprise value with adjusted EBITDA multiples near 6x, despite showing improved margins and revenue per patient. Key risks include $4 billion net debt, control by KKR, and uncertain reimbursement policies. Investors await clearer signs of debt reduction before considering investment.
At Google Next 2026, Google Cloud Security used Instruqt's hands-on platform to train over 150 practitioners on Agentic AI capabilities. Participants built their own AI agents in dedicated Google Cloud Vertex AI environments, gaining practical experi...
Last week, large-cap stocks in sectors like technology, electric vehicles, data centers, and healthcare experienced declines due to weak earnings guidance, regulatory worries, rising bond yields, and increased competition. Notable losers included Int...
Strategy Inc. paused its bitcoin purchases, shifting focus to bond buying and managing debt after increasing its bitcoin holdings to 843,738 BTC valued near $64.45 billion. CEO Michael Saylor's comment about the 'BitVac' charging suggests the company...
XRP has seen a 57.3% decline in whale transactions over $1 million in the past nine days, dropping from 157 to 67. This decrease reflects a pause in large investor activity rather than a sell-off, leading to tighter price ranges and reduced volatilit...
Morpho's price surged 10.3% driven by increased activity in the perpetual market, where long trades now make up 54% of volume and the long-to-short ratio is 1.27. Open interest and funding rates have risen, signaling strong bullish sentiment among in...
